FindTrial
Sign In

Using Information Intelligent platform to implement chronic Disease Management of Psoriasis Biotherapy

Using Information Intelligent platform to implement chronic Disease Management of Psoriasis Biotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024852
Enrollment
Unknown
Registered
2019-07-31
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

Case series:Nil

Sponsors

The University of Hong Kong-Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with clinically diagnosed psoriasis and treated with biological agents; 2. Any age and genders; 3. Communicate with the prescribing physician through the smartphone-side login management platform; 4. Voluntary participation in the study, able to adhere to follow-up and participate in the long-term management of psoriasis, signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with latent tuberculosis, hepatitis B, and tumor history, and those who use screening for biological agents; 2. Information registration and long-term follow-up managers are not acceptable.

Countries

China

Contacts

Public ContactLiu Xiaoming

The University of Hong Kong-Shenzhen Hospital

liuxm@hku-szh.org+86 18307556805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026